Sangam V Kandasami1, Charalampos Mamoulakis2, Ahmed R El-Nahas3, Timothy Averch4, O Levent Tuncay5, Ashish Rawandale-Patil6, Luigi Cormio7, Jean J de la Rosette8. 1. Department of Urology, Vedanayagam Hospital and Postgraduate Institute, Tamilnadu, India. 2. Department of Urology, University Hospital of Heraklion, University of Crete, Medical School, Heraklion, Crete, Greece. 3. Department of Urology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt. 4. Division of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. 5. Department of Urology, Pamukkale University Faculty of Medicine, Denizli, Turkey. 6. Institute of Urology, Division of Tejnaksh Healthcare, Dhule, India. 7. Department of Urology, University of Foggia, Foggia, Italy. 8. Department of Urology, AMC University Hospital, Amsterdam, The Netherlands. Electronic address: j.j.delarosette@amc.uva.nl.
Abstract
BACKGROUND: The Clinical Research Office of the Endourological Society (CROES) undertook the Ureteroscopy Global Study to establish a prospective global database to examine the worldwide use of ureteroscopy (URS) and to determine factors affecting outcome. OBJECTIVE: To investigate the influence of case volume on the outcomes of URS for ureteral stones. DESIGN, SETTING, AND PARTICIPANTS: The URS Global Study collected prospective data on consecutive patients with urinary stones treated with URS at 114 centres worldwide for 1 yr. Centres were identified as low or high volume based on the median overall annual case volume. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Pre- and intraoperative characteristics, and postoperative outcomes in patients at low- and high-volume centres were compared. The relationships between case volume and stone-free rate (SFR), stone burden, complications, and hospital stay were explored using multivariate regression analysis. RESULTS AND LIMITATIONS: Across all centres, the median case volume was 67; 58 and 56 centres were designated as low volume and high volume, respectively. URS procedures at high-volume centres took significantly less time to conduct. Mean SFR was 91.9% and 86.3% at high- and low-volume centres, respectively (p<0.001); the adjusted probability of a stone-free outcome increased with increasing case volume (p<0.001). Patients treated at a high-volume centre were less likely to need retreatment, had shorter postoperative hospital stay, were less likely to be readmitted within 3 mo, and had fewer and less severe complications. At case volumes approximately >200, the probability of complications decreased with increasing case volume (p=0.02). The study is limited by the heterogeneity of participating centres and surgeons and the inclusion of patients treated by more than one approach. CONCLUSIONS: In the treatment of ureteral stones with URS, high-volume centres achieve better outcomes than low-volume centres. Several outcome measures for URS improve with an increase in case volume. PATIENT SUMMARY: Outcomes following treatment of ureteral stones by ureteroscopy (URS) were studied in a large group of patients at centres worldwide. The proportion of successful procedures (ie, those in which patients became stone free) increased as the annual volume of URS at a hospital increased. Hospital stays were shorter and postoperative complications were less likely at high-volume hospitals. We conclude that for URS, the best outcomes are seen in patients treated at high-volume hospitals.
BACKGROUND: The Clinical Research Office of the Endourological Society (CROES) undertook the Ureteroscopy Global Study to establish a prospective global database to examine the worldwide use of ureteroscopy (URS) and to determine factors affecting outcome. OBJECTIVE: To investigate the influence of case volume on the outcomes of URS for ureteral stones. DESIGN, SETTING, AND PARTICIPANTS: The URS Global Study collected prospective data on consecutive patients with urinary stones treated with URS at 114 centres worldwide for 1 yr. Centres were identified as low or high volume based on the median overall annual case volume. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Pre- and intraoperative characteristics, and postoperative outcomes in patients at low- and high-volume centres were compared. The relationships between case volume and stone-free rate (SFR), stone burden, complications, and hospital stay were explored using multivariate regression analysis. RESULTS AND LIMITATIONS: Across all centres, the median case volume was 67; 58 and 56 centres were designated as low volume and high volume, respectively. URS procedures at high-volume centres took significantly less time to conduct. Mean SFR was 91.9% and 86.3% at high- and low-volume centres, respectively (p<0.001); the adjusted probability of a stone-free outcome increased with increasing case volume (p<0.001). Patients treated at a high-volume centre were less likely to need retreatment, had shorter postoperative hospital stay, were less likely to be readmitted within 3 mo, and had fewer and less severe complications. At case volumes approximately >200, the probability of complications decreased with increasing case volume (p=0.02). The study is limited by the heterogeneity of participating centres and surgeons and the inclusion of patients treated by more than one approach. CONCLUSIONS: In the treatment of ureteral stones with URS, high-volume centres achieve better outcomes than low-volume centres. Several outcome measures for URS improve with an increase in case volume. PATIENT SUMMARY: Outcomes following treatment of ureteral stones by ureteroscopy (URS) were studied in a large group of patients at centres worldwide. The proportion of successful procedures (ie, those in which patients became stone free) increased as the annual volume of URS at a hospital increased. Hospital stays were shorter and postoperative complications were less likely at high-volume hospitals. We conclude that for URS, the best outcomes are seen in patients treated at high-volume hospitals.
Authors: Nicholas E Boxall; Fanourios Georgiades; Saiful Miah; Laurian Dragos; James Armitage; Tevita F Aho Journal: World J Urol Date: 2021-05-12 Impact factor: 4.226
Authors: Jonathan Cloutier; Ken Anson; Guido Giusti; Michael Grasso; Guido Kamphuis; Sven Lahme; Evangelos Liatsikos; Anup Patel; Margaret S Pearle; Luc Valiquette; Olivier Traxer Journal: World J Urol Date: 2017-07-25 Impact factor: 4.226
Authors: Steffen Lebentrau; Thomas Enzmann; Mike Lehsnau; Frank Christoph; Martin Schostak; Matthias May Journal: World J Urol Date: 2018-08-09 Impact factor: 4.226
Authors: Tae Jin Kim; In Jae Lee; Jung Keun Lee; Hak Min Lee; Chang Wook Jeong; Sung Kyu Hong; Seok-Soo Byun; Jong Jin Oh Journal: World J Urol Date: 2018-10-03 Impact factor: 4.226
Authors: Lennert Eismann; Alexander Kretschmer; Markus J Bader; Sabine Kess; Christian G Stief; Frank Strittmatter Journal: World J Urol Date: 2021-01-02 Impact factor: 4.226